Phase I study to assess the effect of food on AZD1775 pharmacokinetics in patients with Advanced Solid Tumours

Trial Identifier: D6014C00005
Sponsor: AstraZeneca
Collaborator:
Quintiles, Inc.
NCTID:: NCT03315091
Start Date: September 2017
Primary Completion Date: April 2018
Study Completion Date: April 2018
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
English Translation
Dutch Translation
French Translation

Trial Locations

Country Location
France Bordeaux Cedex, France, 33075
France Saint Herblain, France, 44805
Netherlands Amsterdam, Netherlands, 1066 CX
Netherlands Amsterdam, Netherlands, 1081 HV
Netherlands Maastricht, Netherlands, 6229 HX
United Kingdom Glasgow, United Kingdom, G12 0YN
United Kingdom Manchester, United Kingdom, M20 4BX